CREBBP c.4920_4922del ;(p.P1641del)

Variant ID: 16-3781443-AGGC-A

NM_004380.2(CREBBP):c.4920_4922del;(p.P1641del)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma.

Diagnostic Pathology
Choi, Sarah M SM; Andea, Aleodor A AA; Wang, Min M; Behdad, Amir A; Shao, Lina L; Zhang, Yanming Y; Lu, Xinyan X; Dittmann, David D; Castro, Juan J; Chen, Yi-Hua YH; Gao, Juehua J
Publication Date: 2018-10-15

Variant appearance in text: CREBBP: 4920_4922del
PubMed Link: 30322385
Variant Present in the following documents:
  • Main text
  • 13000_2018_Article_758.pdf
View BVdb publication page



Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.

Oncogene
Nickerson, M L ML; Witte, N N; Im, K M KM; Turan, S S; Owens, C C; Misner, K K; Tsang, S X SX; Cai, Z Z; Wu, S S; Dean, M M; Costello, J C JC; Theodorescu, D D
Publication Date: 2017-01-05

Variant appearance in text: CREBBP: 4920_4922del
PubMed Link: 27270441
Variant Present in the following documents:
  • onc2016172x3.xls, sheet 3
  • onc2016172x3.xls, sheet 4
View BVdb publication page